About S*BIO Pte

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases.

In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments’ biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds.

Facts about S*BIO Pte
  • Focus : Manufacturer
  • Industry : Biotechnology

Product portfolio of S*BIO Pte

Product portfolio

cancer therapeutics

News about S*BIO Pte

Here you will find S*BIO Pte Ltd